A meta-analysis reported a weight loss of 4.19 kg (4.16%), a decrease in body mass index of 1.55 kg/m 2 , and a decrease in waist circumference of 3.11 cm when liraglutide was used [12]
The LEADER trial (liraglutide) and SUSTAIN-6 trial (semaglutide) both showed reductions in major adverse cardiac events in high-risk populations
Glutathione is a powerful antioxidant that helps protect cells from oxidative stressa factor implicated in the aging of skin and hair follicles
It may help manage blood sugar, reduce heart attack and stroke risk in people with diabetes and known heart disease, and treat kidney problems in diabetic patients
These symptoms often improve with dietary modifications and usually resolve as the body adjusts to the medication
While 2023 data is still pending, Amirshahi said there were 4,413 case records in the National Poison Data System related to GLP-1 receptor agonist drugs, a class of drugs used for type 2 diabetes and weight management